By Nick Renaud-Komiya2015-04-24T12:57:00
The UK president of drug giant AstraZeneca has indicated she would not sign up to another deal similar to the current pharmaceutical pricing scheme unless the NHS makes a ‘substantial’ increase of drugs access.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud